The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.00
Bid: 296.00
Ask: 300.00
Change: -5.50 (-1.82%)
Spread: 4.00 (1.351%)
Open: 295.00
High: 297.00
Low: 295.00
Prev. Close: 301.50
BMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on trading, FY23 results & investigation

26 Jun 2023 07:00

RNS Number : 8117D
Braemar PLC
26 June 2023
 

 

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

 

26 June 2023

 

 

BRAEMAR PLC

("Braemar", the "Company" or the "Group")

 

Update on FY23 trading

Publication of FY23 results & investigation into a 2013 transaction

Braemar (LSE: BMS), a provider of expert investment, chartering, and risk management advice to the shipping and energy markets, provides an update on its annual results for the 12 months ended 28 February 2023 ("FY23") together with details of an on-going investigation into a historic transaction.

 

Trading Update

As announced on 22 March 2023, Braemar is pleased to reconfirm its expectation of reporting record revenue and record profitability for FY23, with revenue for the year of not less than £150m (2022: £101.3m), underlying operating profit of not less than £20m (2022: £10.1m) and net cash of £6.9m at the year end. It remains the board's intention to recommend a final dividend of 8 pence per share (2022: 7 pence) to shareholders for approval at the forthcoming annual general meeting, representing a dividend for the year of 12 pence per share, a 33% increase over the previous year (2022: 9 pence).

 

Publication of FY23 results & investigation into 2013 transaction

During the past two years, in addition to establishing and developing the Group's growth strategy, the board has focused on ensuring that proper procedures are in place to deliver good practice throughout the business as it scales. As part of this work, the board and the Group's auditors have been carrying out an investigation into a particular transaction of circa $3m, which originated in 2013, and involves payments being made through to 2017.

 

The board is not presently comfortable with the manner in which the transaction has been historically represented and the remaining liability recorded in the Company's balance sheet. Upon conclusion of the investigation, should this liability be released, it would not affect the underlying trading profit or cash position of the Company for FY23.

 

The investigation into this transaction and any related matters which may arise, is still ongoing. The board has appointed FRP, an independent specialist firm to assist with the investigation and has established a specific investigation committee, chaired by the Group's non-executive Chairman, to oversee the matter. As a result, the Company's Final results for FY23 will be delayed until this work has completed and will not be published by 30 June 2023.

 

Under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, the Company is required to publish its audited FY23 results by 30 June 2023. As the Company does not expect to be able to comply with this requirement, the Group will request that trading in the Company's ordinary shares be suspended with effect from 7.30 a.m. on 3 July 2023.

 

The Company will provide further updates on expected timings for publication of its FY23 results in due course. The Company expects to request a restoration of the listing of its ordinary shares on publication of its FY23 results.

 

 

 

ENDS

For further information, contact:

Braemar Plc

James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Nick Stone, Chief Financial Officer

Investec Bank plc

Gary Clarence / Harry Hargreaves / Alice King

Tel +44 (0) 20 7597 5970

Cenkos Securities plc

 

Ben Jeynes / Max Gould (Corporate Finance)

 

Alex Pollen / Leif Powis (Sales)

 

Tel +44 (0) 20 7397 8900

Buchanan

Charles Ryland / Jamie Hooper / Jack Devoy

Tel +44 (0) 20 7466 5000

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUCCQUPWGRA
Date   Source Headline
13th Jul 201110:03 amRNSBlocklisting Six Monthly Return
13th Jul 20119:53 amRNSBlocklisting Six Monthly Return
23rd Jun 201112:04 pmRNSResult of General Meeting
22nd Jun 201112:00 pmRNSInterim Management Statement
7th Jun 201112:32 pmRNSAnnual Information Update
25th May 201112:21 pmRNSHolding(s) in Company
20th May 20113:33 pmRNSPosting of Annual Report and AGM Notice
20th May 201110:42 amRNSHolding(s) in Company
19th May 20113:49 pmRNSDirector/PDMR Shareholding
18th May 20113:46 pmRNSHolding(s) in Company
18th May 20113:40 pmRNSTotal Voting Rights
12th May 20113:13 pmRNSReplacement - Director/PDMR Shareholding
12th May 20111:40 pmRNSDirector/PDMR Shareholding
9th May 20117:05 amRNSAcquisition
9th May 20117:00 amRNSFinal Results
28th Apr 201110:18 amRNSNotice of Results
1st Feb 20113:56 pmRNSDirector/PDMR Shareholding
1st Feb 20117:00 amRNSTotal Voting Rights
17th Jan 20112:37 pmRNSBlocklisting Six Monthly Return
17th Jan 20112:35 pmRNSBlocklisting Six Monthly Return
12th Jan 20117:00 amRNSIMS & appointment of non-executive director
1st Dec 201010:22 amRNSHolding in Company
5th Nov 201012:24 pmRNSChange of Auditor
4th Nov 20105:14 pmRNSHolding(s) in Company
3rd Nov 20102:05 pmRNSDirector/PDMR Shareholding
26th Oct 20107:00 amRNSHalf Yearly Report
26th Oct 20107:00 amRNSHalf Yearly Report
19th Oct 20107:00 amRNSNotice of Results
17th Sep 20104:35 pmRNSPrice Monitoring Extension
16th Sep 20104:35 pmRNSPrice Monitoring Extension
8th Sep 201012:16 pmRNSHolding(s) in Company
27th Aug 20107:00 amRNSDirector/PDMR Shareholding
3rd Aug 201011:06 amRNSTotal Voting Rights
3rd Aug 20107:00 amRNSChange of Adviser
29th Jun 20104:40 pmRNSSecond Price Monitoring Extn
29th Jun 20104:35 pmRNSPrice Monitoring Extension
24th Jun 20105:08 pmRNSDirector/PDMR Shareholding
24th Jun 20104:06 pmRNSResult of General Meeting
23rd Jun 201012:00 pmRNSAGM and Interim Management Statement
1st Jun 201010:05 amRNSDirector/PDMR Shareholding
20th May 201012:28 pmRNSHolding(s) in Company
10th May 20107:00 amRNSFinal Results
8th Mar 201012:27 pmRNSAppointment of company secretary
26th Feb 20105:04 pmRNSTotal Voting Rights
4th Feb 20108:56 amRNSHolding(s) in Company
29th Jan 20101:41 pmRNSTotal Voting Rights
15th Jan 20107:00 amRNSInterim Management Statement
7th Jan 201010:22 amRNSBlocklisting Interim Review
31st Dec 200910:11 amRNSTotal Voting Rights
7th Dec 20099:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.